Carsten Schade Larsen
Overview
Explore the profile of Carsten Schade Larsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Florescu A, Bryrup T, Larsen C, Larsen L, Wiese L, Luttichau H, et al.
J Neurol
. 2025 Mar;
272(3):241.
PMID: 40029446
Background: Our aim was to characterize the clinical presentation and outcome in adults with tick-borne encephalitis (TBE) and to determine the incidence and test activity of TBE in Denmark. Methods:...
2.
Hojbjerg Lassen M, Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, et al.
JACC Adv
. 2024 Nov;
3(12):101391.
PMID: 39606218
Background: Despite evidence demonstrating that influenza vaccination is associated with reduced risk of cardiovascular events and all-cause mortality in individuals with diabetes mellitus (DM), vaccine uptake remains suboptimal. Objectives: The...
3.
Bhatt A, Johansen N, Vaduganathan M, Modin D, Pareek M, Chatur S, et al.
JAMA Cardiol
. 2024 Nov;
10(1):78-86.
PMID: 39550717
Importance: Influenza vaccination in patients with acute myocardial infarction (AMI) reduces major adverse cardiac events and is strongly recommended in clinical practice guidelines. Effective strategies to improve vaccination are needed...
4.
Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, Claggett B, et al.
JAMA
. 2024 Oct;
332(22):1900-1911.
PMID: 39392741
Importance: Despite strong worldwide guideline recommendations, influenza vaccination rates remain suboptimal among young and middle-aged patients with chronic diseases. Effective scalable strategies to increase vaccination are needed. Objective: To investigate...
5.
Christensen J, Johansen N, Janstrup K, Modin D, Skaarup K, Nealon J, et al.
J Infect
. 2024 Sep;
89(5):106276.
PMID: 39303788
Objectives: Morning influenza vaccination enhances antibody response. In this post hoc analysis of the DANFLU-1 trial, we sought to evaluate the association between time of day for vaccination (ToV) and...
6.
Bartholdy K, Johansen N, Janstrup K, Modin D, Nealon J, Samson S, et al.
J Am Coll Cardiol
. 2024 Sep;
PMID: 39217544
No abstract available.
7.
Christensen J, Johansen N, Modin D, Janstrup K, Nealon J, Samson S, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Aug;
18(2):e011496.
PMID: 39215646
Background: Influenza vaccination reduces the risk of adverse outcomes in patients with cardiovascular disease (CVD). We sought to evaluate whether the presence of CVD modified the relative effectiveness of the...
8.
Johansen N, Vaduganathan M, Bhatt A, Modin D, Chatur S, Claggett B, et al.
Nat Med
. 2024 Aug;
30(11):3142-3149.
PMID: 39215149
Digital letter interventions have proven effective in increasing influenza vaccination rates. In this trial, we sought to further refine these strategies and investigated whether the effectiveness of the strategies could...
9.
Hybel T, Sorensen E, Enemark M, Hemmingsen J, Simonsen A, Lauridsen K, et al.
AIDS
. 2024 Aug;
38(14):1897-1906.
PMID: 39178160
Objective: Individuals with HIV experience an increased risk of lymphoma, making this an important cause of death among people with HIV. Nevertheless, little is known regarding the underlying genetic aberrations,...
10.
Slot M, Rasmussen T, Norgaard M, Larsen C, Ehlers L
Pharmacoecon Open
. 2024 Jul;
8(6):847-856.
PMID: 39080141
Objective: To estimate the costs and cost-effectiveness of introducing highly active antiretroviral therapy (HAART) in Denmark based on real-world evidence for the three treatment eras pre-HAART (1985-1995), early HAART (1996-2005),...